Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction

NCT03037229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-12-07

No results posted yet for this study

Summary

Is the Smartphone ECG (electrocardiogram) an acceptable replacement for a standard ECG in the identification of STEMI (ST Elevation Myocardial Infarction).

Conditions

  • STEMI

Interventions

DEVICE

Smartphone ECG

DEVICE

Standard 12-lead ECG

Sponsors & Collaborators

  • AliveCor

    collaborator INDUSTRY
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Gregory W Barsness, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-29
Primary Completion
2018-01-30
Completion
2018-12-06
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037229 on ClinicalTrials.gov